Organogenesis Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Organogenesis Holdings's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4% to $433,140,000. Profit margin reached 1%. Total operating expenses were $314,134,000.

Profit Margin

Organogenesis Holdings Inc. (NASDAQ:ORGO): Profit margin
2016 0 -208.69K
2017 0 -2.09M
2018 193.44M -64.83M -33.51%
2019 260.98M -40.45M -15.5%
2020 338.29M 17.23M 5.09%
2021 468.05M 94.20M 20.13%
2022 450.89M 15.53M 3.44%
2023 433.14M 4.94M 1.14%

ORGO Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
433.14M450.89M468.05M338.29M260.98M193.44M00
Cost of revenue
106.48M105.01M114.19M87.31M75.94M68.80M4.59M208.69K
Gross profit
326.65M345.87M353.86M250.97M185.03M124.64M-4.59M-208.69K
Operating exp.
Research and development
44.38M39.76M30.74M20.08M14.79M10.74M00
Selling and marketing
5.22M4.81M5.52M2.72M1.05M000
Total operating expenses
314.13M323.57M280.94M223.56M214.49M172.70M4.59M208.69K
Operating income
12.52M22.30M72.91M27.41M-29.45M-51.55M-4.59M208.69K
Other income (expenses), net
-2.13M-2.02M-9.13M-8.93M-10.84M-5.89M3.40M-417.39K
Income before tax
10.39M20.28M63.78M18.47M-40.30M-64.74M-2.09M-208.69K
Income tax expense
5.44M4.75M-31.11M530K150K84K-52.51K0
Net income
4.94M15.53M94.20M17.23M-40.45M-64.83M-2.09M-208.69K
Earnings per share
Basic EPS
0.030.120.730.16-0.44-0.94-0.03-0.00
Diluted EPS
0.030.120.70.15-0.44-0.94-0.03-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source